enVVeno Medical
NVNO
2 hedge funds and large institutions have $190K invested in enVVeno Medical in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$151K |
| 2 |
Jane Street
New York
|
+$73.7K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Goldman Sachs
New York
| $127K | +$151K | +39 | New |
|
|
2
Jane Street
New York
| $62K | +$73.7K | +19 | New |
|
3
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
NVNO Hedge Fund Activity: Q2 2018 in Review
2 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q2 2018, worth a combined $190K.
Buyers outnumbered sellers: 2 funds opened new NVNO positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $151K.
- 2 institutional investors held enVVeno Medical (NVNO) as of Q2 2018, up from 0 in Q1 2018.
- Funds reported $190K of enVVeno Medical stock for Q2 2018.
- 2 funds opened new enVVeno Medical positions in Q2 2018 and 0 closed out, a net change of +2 holders.
- The largest enVVeno Medical buyer in Q2 2018 was Goldman Sachs, an estimated $151K added.
Based on aggregated 13F filings for Q2 2018.